Core Viewpoint - MicroPort Medical reported a revenue of approximately $547.5 million for the first half of 2025, reflecting a year-on-year decrease of 2% while the company narrowed its net loss to $46.6 million, a reduction of 51.9% compared to the previous year [1] Financial Performance - Revenue for the first half of 2025 was approximately $547.5 million, down 2% year-on-year [1] - The net loss attributable to equity shareholders was $46.6 million, which represents a 51.9% reduction in losses compared to the same period last year [1] - Basic loss per share was 2.53 cents [1] Cost Management - The total expenses for sales, management, and research and development decreased by 14.5% compared to the same period in 2024 [1] - The operating expense ratio improved by 8.1 percentage points year-on-year [1] - The research and development expense ratio decreased from 20.6% to 13.2% [1] Non-Core Business Disposal - The company completed the disposal of several non-core businesses during the reporting period, resulting in a positive gain of $26.1 million [1]
港股异动 | 微创医疗(00853)绩后涨超5% 中期权益股东应占亏损4660.2万美元 同比减亏51.9%